Travere Therapeutics plans $400M convertible notes offering
Travere Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $47.18
-4.9% in 3d after detection
Post-detection moves
1h
—
1d
-0.1%
3d
-4.9%
7d
-1.6%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS